PMC:7161517 / 7259-7416 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T35","span":{"begin":31,"end":44},"obj":"Body_part"}],"attributes":[{"id":"A35","pred":"fma_id","subj":"T35","obj":"http://purl.org/sig/ont/fma/fma14067"}],"text":"ediated loss of membrane-bound cardiomyocyte ACE2 correlated with the upregulation of TACE/ADAM17 activity, which was prevented with AT1 receptor blockade (3"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T44","span":{"begin":133,"end":136},"obj":"Disease"}],"attributes":[{"id":"A44","pred":"mondo_id","subj":"T44","obj":"http://purl.obolibrary.org/obo/MONDO_0008840"}],"text":"ediated loss of membrane-bound cardiomyocyte ACE2 correlated with the upregulation of TACE/ADAM17 activity, which was prevented with AT1 receptor blockade (3"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T81","span":{"begin":16,"end":24},"obj":"http://purl.obolibrary.org/obo/UBERON_0000158"},{"id":"T82","span":{"begin":31,"end":44},"obj":"http://purl.obolibrary.org/obo/CL_0000746"},{"id":"T83","span":{"begin":98,"end":106},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"}],"text":"ediated loss of membrane-bound cardiomyocyte ACE2 correlated with the upregulation of TACE/ADAM17 activity, which was prevented with AT1 receptor blockade (3"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T222","span":{"begin":16,"end":24},"obj":"GO:0016020"},{"id":"T223","span":{"begin":31,"end":44},"obj":"CL:0000746"},{"id":"T224","span":{"begin":45,"end":49},"obj":"PR:000003622;G_3;PG_10"},{"id":"T225","span":{"begin":91,"end":97},"obj":"PR:000001279"},{"id":"T226","span":{"begin":133,"end":136},"obj":"PR:000001251"},{"id":"T29306","span":{"begin":54,"end":68},"obj":"UBERON:0004535"},{"id":"T37860","span":{"begin":82,"end":92},"obj":"GO:0065007"},{"id":"T4521","span":{"begin":101,"end":111},"obj":"CHEBI:35222;CHEBI:35222"}],"text":"ediated loss of membrane-bound cardiomyocyte ACE2 correlated with the upregulation of TACE/ADAM17 activity, which was prevented with AT1 receptor blockade (3"}

{"project":"LitCovid-PubTator","denotations":[{"id":"383","span":{"begin":45,"end":49},"obj":"Gene"},{"id":"384","span":{"begin":86,"end":90},"obj":"Gene"},{"id":"385","span":{"begin":91,"end":97},"obj":"Gene"}],"attributes":[{"id":"A383","pred":"tao:has_database_id","subj":"383","obj":"Gene:70008"},{"id":"A384","pred":"tao:has_database_id","subj":"384","obj":"Gene:11491"},{"id":"A385","pred":"tao:has_database_id","subj":"385","obj":"Gene:11491"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ediated loss of membrane-bound cardiomyocyte ACE2 correlated with the upregulation of TACE/ADAM17 activity, which was prevented with AT1 receptor blockade (3"}